iBio (IBIO) Change in Acquisitions & Divestments (2021 - 2023)
iBio (IBIO) posted quarterly Change in Acquisitions & Divestments of $5.9 million for Q1 2023, up 207.75% year-over-year from $1.9 million in Q1 2022, and up 249.5% quarter-over-quarter from $1.7 million in Q4 2022.
iBio (IBIO) Change in Acquisitions & Divestments (2021 - 2023) Analysis & Trends
iBio (IBIO) has reported Change in Acquisitions & Divestments for 3 consecutive years, with $5.9 million the latest figure, recorded in Q1 2023.
- In Q1 2023, Change in Acquisitions & Divestments rose 207.75% year-over-year to $5.9 million; the TTM figure through Jun 2023 stood at $10.8 million (down 20.42% YoY), while the FY2023 annual figure was $6.7 million, down 50.51% from the prior year.
- Change in Acquisitions & Divestments rose to $5.9 million in Q1 2023 per IBIO's latest filing, from $1.7 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $13.6 million in Q2 2022 and bottomed at -$5.5 million in Q1 2022.
- Historically, Change in Acquisitions & Divestments has averaged $3.2 million across 3 years, with a median of $2.5 million in 2021.
- On a YoY basis, Change in Acquisitions & Divestments climbed as much as 444.72% in 2022 and fell as far as 467.4% in 2022.
- iBio's Change in Acquisitions & Divestments stood at $3.1 million in 2021, then slumped by 45.39% to $1.7 million in 2022, then surged by 249.5% to $5.9 million in 2023.
- Business Quant data shows IBIO's Change in Acquisitions & Divestments at $5.9 million in Q1 2023, $1.7 million in Q4 2022, and $3.2 million in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 5.94 Mn |
| Mar 31, 2023 | 5.94 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Dec 31, 2022 | 1.70 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Sep 30, 2022 | 3.20 Mn |
| Jun 30, 2022 | 13.62 Mn |
| Jun 30, 2022 | 13.62 Mn |
| Mar 31, 2022 | -5.51 Mn |
| Mar 31, 2022 | -5.51 Mn |
| Dec 31, 2021 | 3.11 Mn |
| Dec 31, 2021 | 3.11 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Jun 30, 2021 | 2.50 Mn |
| Mar 31, 2021 | 1.50 Mn |
| Mar 31, 2021 | 1.50 Mn |